Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable

Journal of Urology

Volumn 169, Issue 5, 2003, Pages 1720-1723

  Hugosson, Jonas ^a   Aus, Gunnar ^a   Lilja, Hans ^a   Lodding, Pär ^a   Pihl, Carl Gustaf ^a   Pileblad, Erik ^a  

^a NONE

Author keywords

Epidemiology; Mass screening; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; SAFETY; SWEDEN; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0037404941     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000061183.43229.2e     Document Type: Article

References (20)

1. Hugosson, J., Aus, G. and Norlen, L.: Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer. Urol Clin North Am, 23: 557, 1996
2. Auvinen, A., Rietbergen, J. B., Denis, L. J., Schroder, F. H. and Prorok, P. C.: Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. J Med Screen, 3: 97, 1996
3. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948, 1993
4. Mettlin, C., Jones, G., Averette, H., Gusberg, S. B. and Murphy, G. P.: Defining and updating the American Cancer Society guidelines for cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin, 43: 42, 1993
5. Etzioni, R., Cha, R. and Cowen, M. E.: Serial PSA screening for prostate cancer: a computer model evaluates competing strategies. J Urol, suppl., 161: 291, abstract 1128, 1999
6. Brawer, M. K., Beatie, J., Wener, M. H., Vessella, R. L., Preston, S. D. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol, 150: 106, 1993
7. Gleason, D. F.: Histologic grading and staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea and Febiger, pp. 171-198, 1977
8. Gustafsson, O., Norming, U., Almgård, L.-E., Fredriksson, Å., Gustavsson, G., Harvig, B. et al: Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. J Urol, 148: 1827, 1992
9. Hugosson, J., Aus, G., Becker, C., Carlsson, S., Eriksson, H., Lilja, H. et al: Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison between two population-based studies in Sweden. BJU Int, 85: 1078, 2000
10. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA, 273: 289, 1995
11. Ito, K., Kubota, Y., Yamamoto, T., Suzuki, K., Fukabori, Y., Kurokawa, K. et al: Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less. Cancer, 91: 744, 2001
12. Carter, H. B., Epstein, J. I., Chan, D. W., Fozard, J. L. and Pearson, J. D.: Recommended prostate-specific antigen testing intervals for the detection of curable cancer. JAMA, 277: 1456, 1997
13. Karakiewicz, P. I., Bazinet, M., Aprikian, A. G., Trudel, C., Aronson, S., Nachabe, M. et al: Outcome of sextant biopsy according to gland volume. Urology, 49: 55, 1997
14. Levine, M. A., Ittman, M., Melamed, J. and Lepor, H.: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol, 159: 471, 1998
15. Eskew, L. A., Bare, R. L. and McCullough, D. L.: Systemic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol, 157: 199, 1997
16. Aus, G., Bergdahl, S., Hugosson, J., Lodding, P., Pihl, C. G. and Pileblad, E.: Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50-66 years. Implications for sampling order. Eur Urol, 39: 655, 2001
17. Applewhite, J. C., Matlaga, B. R. and McCullough, D. L.: Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol, 168: 500, 2002
18. Fracheboud, J., de Koning, H. J., Beemsterboer, P. M., Boer, R., Verbeek, A. L., Hendriks, J. H. et al: Interval cancers in the Dutch breast cancer screening programme. Br J Cancer, 81: 912, 1999
19. Schroder, F. H., Roobol-Bouts, M., Vis, A. N., van der Kwast, T. and Kranse, R.: Prostate-specific antigen-based early detection of prostate cancer - validation of screening without rectal examination. Urology, 57: 83, 2001
20. Schroder, F. H., van der Maas, P., Beemsteboer, P., Kruger, A. B., Hoedemaeker, R., Rietbergen, J. et al: Evaluation of digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst, 90: 1817, 1998